ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 90 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.99 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $724,796 | +236.4% | 228,642 | +427.5% | 0.00% | – |
| Q2 2023 | $215,431 | -90.0% | 43,346 | -90.0% | 0.00% | -100.0% |
| Q1 2023 | $2,149,000 | +1480.1% | 435,020 | +3354.5% | 0.01% | – |
| Q3 2022 | $136,000 | -99.0% | 12,593 | -98.7% | 0.00% | -100.0% |
| Q4 2021 | $14,153,000 | +18.9% | 948,624 | +107.8% | 0.03% | -51.9% |
| Q2 2021 | $11,908,000 | +364.1% | 456,591 | +245.9% | 0.05% | +107.7% |
| Q1 2020 | $2,566,000 | -35.5% | 132,006 | -13.8% | 0.03% | -3.7% |
| Q4 2019 | $3,977,000 | +657.5% | 153,105 | +684.2% | 0.03% | +575.0% |
| Q2 2019 | $525,000 | -85.3% | 19,524 | -84.2% | 0.00% | -76.5% |
| Q1 2019 | $3,564,000 | – | 123,284 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |